AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read moreMon, 18th Nov 2019 16:00
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.
Read more(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit.
Read more(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Read moreGenedrive PLC - Manchester-based molecular diagnostics company - Reports that 21% of its shareholders voted against resolution 3 for the reappointment Tom Lindsay as a director at its annual general meeting on Thursday. 32% of its shareholders voted against resolution 5 for the reappointment of David Budd as a director, and 25% of shareholders voted against resolution 6 for the reappointment of Ian Gilham as a director. Adds that 25% of shareholders voted against resolution 10, to authorise the directors to allot equity securities in the capital.
Read moreFriday 23 December | |
Plexus Holdings PLC | AGM |
Wildcat Petroleum PLC | AGM |
Monday 26 December | |
no events scheduled | |
Tuesday 27 December | |
Zambeef Products PLC | AGM |
Wednesday 28 December | |
Evrima PLC | AGM |
Greencare Capital PLC | GM re proposed name change |
Lift Global Ventures PLC | GM re proposed expansion within the energy sector |
Thursday 29 December | |
Amte Power PLC | AGM |
ADVFN PLC | AGM |
Genedrive PLC | AGM |
Hotel Chocolat Group PLC | AGM |
Lekoil Ltd | EGM re proposed settlement and name change |
Online Blockchain PLC | AGM |
PetroNeft Resources PLC | AGM |
SkinBioTherapeutics PLC | AGM |
Copyright 2022 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - Genedrive PLC on Monday reported a substantially widened pretax loss as revenue slumped due to a lack of Covid-19 revenue.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
Read moreTuesday 15 November | |
AdEPT Technology Group PLC | Half Year Results |
BAE Systems PLC | Trading Statement |
Gear4Music PLC | Half Year Results |
Imperial Brands PLC | Full Year Results |
Land Securities Group PLC | Half Year Results |
Melrose Industries PLC | Trading Statement |
Ninety One PLC and Ltd | Half Year Results |
R&Q Insurance Holdings Ltd | Q1 Results |
Speedy Hire PLC | Half Year Results |
Vesuvius PLC | Trading Statement |
Vodafone Group PLC | Half Year Results |
Wincanton PLC | Half Year Results |
Workspace Group PLC | Half Year Results |
Wednesday 16 November | |
Aristocrat Leisure Ltd | Full Year Results |
Bridgepoint Group PLC | Trading Statement |
British Land Co PLC | Half Year Results |
Castings PLC | Half Year Results |
CMC Markets PLC | Half Year Results |
Enteq Technologies PLC | Half Year Results |
Experian PLC | Half Year Results |
Hill & Smith PLC | Trading Statement |
Mediclinic International PLC | Half Year Results |
Nightcap PLC | Full Year Results |
Premier Foods PLC | Half Year Results |
Renold PLC | Half Year Results |
Sage Group PLC | Full Year Results |
Schroder Global Real Estate Securities | Half Year Results |
Schroder Real Estate Investment Trust Ltd | Half Year Results |
SSE PLC | Half Year Results |
Thursday 17 November | |
Burberry Group PLC | Half Year Results |
Close Brothers Group PLC | Trading Statement |
Fuller, Smith & Turner PLC | Half Year Results |
Grainger PLC | Full Year Results |
Great Portland Estates PLC | Half Year Results |
Halma PLC | Half Year Results |
Integrated Diagnostics Holdings PLC | Q3 Results |
Intermediate Capital Group PLC | Half Year Results |
International Distributions Services PLC | Half Year Results |
Investec PLC and Ltd | Half Year Results |
Keller Group PLC | Trading Statement |
Kier Group PLC | Trading Statement |
Mitie Group PLC | Half Year Results |
Pershing Square Holdings Ltd | Q3 Results |
Redcentric PLC | Half Year Results |
Seraphim Space Investment Trust PLC | Q1 Results |
Spirax-Sarco Engineering PLC | Trading Statement |
Syncona Ltd | Half Year Results |
Tyman PLC | Trading Statement |
Virgin Money UK PLC | Full Year Results |
Zytronic PLC | Full Year Results |
Friday 18 November | |
Bank of Cyprus Holdings PLC | Q3 Results |
Liontrust Asset Management PLC | Half Year Results |
Monday 21 November | |
Big Yellow Group PLC | Half Year Results |
Compass Group PLC | Full Year Results |
Dialight PLC | Trading Statement |
Diploma PLC | Full Year Results |
Equipmake Holdings PLC | Full Year Results |
Genedrive PLC | Full Year Results |
Molten Ventures PLC | Half Year Results |
MTI Wireless Edge Ltd | Q3 Results |
NextEnergy Solar Fund Ltd | Half Year Results |
Polar Capital Holdings PLC | Half Year Results |
Sirius Real Estate Ltd | Half Year Results |
SysGroup PLC | Half Year Results |
Virgin Money UK PLC | Full Year Results |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
(Alliance News) - Genedrive PLC on Wednesday said it has started engagement with the US Food & Drug Administration to progress the approval of its MT-RNR1 product range into the US.
Read more(Sharecast News) - Near-patient molecular diagnostics company Genedrive has started engaging with the US Food and Drug Administration (FDA), it announced on Wednesday, to progress the regulatory approval of its 'MT-RNR1 ID Kit' into the United States.
Read more(Alliance News) - Genedrive PLC on Monday said that its Genedrive MT-RNR1 test has been accelerated by the UK's National Institute for Health & Clinical Excellence.
Read more(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.
Read more(Alliance News) - Genedrive PLC on Monday said the UK's National Institute for Health & Clinical Excellence has begun an evaluation of CYP2C19 genotype testing for Clopidogrel treatment.
Read more(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has started an evaluation of CYP2C19 genotype testing for clopidogrel treatment, via a new NICE diagnostics assessment programme (DAP).
Read more